UGT1A1 and Hyperbilirubinemia: While the transient nature of LNP-encapsulated mRNA therapy was sufficient to rescue the neonatal Ugt1 KO mice, these animals had hyperbilirubinemia levels comparable to phototherapy-rescued Ugt1 KO animals at day 28.